Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell cycle and no end.

Mathewos Tessema1, Ulrich Lehmann, Hans Kreipe

  • 1Institute of Pathology, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.

Virchows Archiv : an International Journal of Pathology
|February 18, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Rare Case of <i>Rhizomucor pusillus</i> Infection in a 3-Year-Old Child with Acute Lymphoblastic Leukemia, Presenting with Lung and Brain Abscesses-Case Report.

Infectious disease reports·2026
Same author

Results of the First Folate Receptor Alpha Testing Trial by the German Quality Assurance Initiative in Pathology (QuIP<sup>®</sup>).

Cancers·2025
Same author

Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

JCO clinical cancer informatics·2025
Same author

BRG1 Loss Is Frequent in Lung Cancer and Transforms Lung Epithelial Cells via Transcriptional and Epigenetic Reprograming.

Cancers·2025
Same author

NMD-insensitive CDH1 mutation as a mechanism for retained E-cadherin protein expression in lobular carcinoma in situ (LCIS).

Histopathology·2025
Same author

[Adult rhabdomyoma : Rare differential diagnosis in frozen section examination].

Pathologie (Heidelberg, Germany)·2025
Same journal

Keratins and desmosomal proteins: Utility for molecular subtype identification in muscle-invasive bladder cancer.

Virchows Archiv : an international journal of pathology·2026
Same journal

Immunohistochemical profiling of ampullary carcinoma: Molecular subtypes, prognostic markers, and the role of Claudin-18.

Virchows Archiv : an international journal of pathology·2026
Same journal

Adult sialoblastoma harbouring FGFR2 p.C382R gene mutation.

Virchows Archiv : an international journal of pathology·2026
Same journal

Response to: comment on "FOXL2 expression in dysgenetic gonads supports the diagnostic possibility of ovotesticular differences of sex development".

Virchows Archiv : an international journal of pathology·2026
Same journal

Role of INSM1 expression in the diagnostic work-up of pancreatic acinar cell carcinoma with special reference to the differential diagnosis with neuroendocrine tumor.

Virchows Archiv : an international journal of pathology·2026
Same journal

Mismatch repair protein deficiency (MMRd) and high microsatellite instability (MSI-H) in gastrointestinal stromal tumour (GIST) - a case report and review of the literature of this exceedingly rare phenotype.

Virchows Archiv : an international journal of pathology·2026
See all related articles

Cell cycle regulation is crucial for preventing cancer. Aberrations in cell cycle control, driven by oncogenes or tumor suppressors, are hallmarks of malignant transformation and tumor development.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Cell cycle regulation governs DNA replication and cell division.
  • Dysregulation of the cell cycle is a key factor in cancer development.
  • Understanding these molecular circuits is vital for cancer research.

Purpose of the Study:

  • To detail the phases of the eukaryotic cell cycle (G1, S, G2, M).
  • To present alterations in cell-cycle machinery components in human malignancies.
  • To discuss the functional consequences of these alterations in cancer.

Main Methods:

  • Review of current knowledge on cell cycle regulation.
  • Detailed description of the four cell cycle phases.
  • Analysis of key cell-cycle components in human tumors.

Related Experiment Videos

Main Results:

  • Cell cycle deregulation arises from overactive promoting factors (oncogenes) or inactive inhibitory factors (tumor suppressors).
  • Both mechanisms are implicated in human tumor development.
  • Specific alterations and their consequences in malignancies are presented.

Conclusions:

  • Aberrations in cell cycle control are fundamental to cancer.
  • Knowledge of cell cycle regulation offers potential for clinical applications.
  • Future research directions in cell cycle and cancer are highlighted.